Kremer J, Bingham C, Cappelli L, et al. Post-appoval comparative safety study of tofacitinib and biological DMARDS: five-year results from a US-based rheumatoid arthritis registry. EULAR 2019; Madrid: Abstract OP0028.
Geen hogere mortaliteit COVID-19 bij NSAID-gebruik
jan 2021 | Artrose, Reumatoïde artritis, Virale infecties